Work

Novel imaging biomarkers predict progression-free survival in stage 3 NSCLC treated with chemoradiation and durvalumab.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.3054

Authors: Khalid Jazieh, Mohammadhadi Khorrami, Anas M. Saad, Mohamed M. Gad, Vidya Sankar Viswanathan, Pingfu Fu, Prabhakar Rajiah, Anant Madabhushi, Nathan A. Pennell

Institutions: Cleveland Clinic, Case Western Reserve University, The University of Texas Southwestern Medical Center, Louis Stokes Cleveland VA Medical Center

Language: English

Topic: Radiomics and Machine Learning in Medical Imaging

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3169600775

Cites:

Cited by: 4

Related to: 10